Amgros 2027 1.486.a
Denmark · København Ø · how to bid here →
Your path to submission
- Deadline: 16 October at 00:00 — 38 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: SWE, DAN, NOR, SWE, DAN, NOR, SWE, DAN, NOR, SWE, DAN, NOR, SWE, DAN, NOR, SWE, DAN, NOR.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Compiled automatically from notice and documents — no guarantee; the procedure's wording is binding.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 1 months (1398 awards, most recently September 2026) — the next award is due around October 2026 by that rhythm. The last award went to B.Braun Medical A/S.n = 1,398
- 88% of this buyer's awards went to companies that had already won here before (1,403 awards since 2024, spread over 170 companies). That is well above the sector norm (68%) — newcomers have a harder time here than elsewhere.n = 1,403 awards since 2024
- The median procedure drew 4 bids (583 procedures with a bid count); 11% ended with a single bidder. Sector: median 4 bids.n = 583
- 495% of the bids received came from small and medium-sized enterprises (583 procedures with a bid mix). Sector: 475%.n = 583
- 36% of awards went to companies from abroad (1,403 awards with a known winner country). Sector average: 29%.n = 1,403
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 07/09/2026.
Clement
References and certificates from your home country count fully across the EU — that is what European procurement law is for.
Foreign bidders
In Denmark · Medical equipment & pharma, 574 contracts went to foreign companies over the last 3 years (of 2,117 recorded awards) — mostly from Sweden, Germany, Finland.
Typical field: median 4 (from 583 awards).
Measured from linked award data; foreign winners bidding through a local subsidiary count as domestic — the true share is higher.
What the buyer is looking for
Amgros I/S (Amgros) er et interessentskab med de 5 regioner som interessenter. Amgros ønsker at indgå rammeaftaler for de lægemidler, der fremgår af de enkelte delkontrakter nedenfor, med henblik på at forsyne interessenternes sygehusapoteker med lægemidler samt eventuelt videresalg til Færøerne og Grønland. Amgros videresælger lægemidlerne til sygehusapotekerne til Amgros’ indkøbspris med et tillæg. Rammeaftalerne er ikke-eksklusive. Rammeaftalerne indgås uden købspligt, og sygehusapotekerne i regionerne er ikke forpligtet til at anvende Amgros’ rammeaftaler.
Description as published (DE).
What you must prove — eligibility criteria
›
Financial ratio required
Udbuddet er et offentligt udbud, og der gælder ikke nogen minimumskrav til egnethed. Kriterium ”finansielt forhold” er således ikke anvendt for udbuddet - men bemærkning om udbuddet er af systemtekniske årsager anført i beskrivelsesfeltet hertil.
›
Financial ratio required
Udbuddet er et offentligt udbud, og der gælder ikke nogen minimumskrav til egnethed. Kriterium ”finansielt forhold” er således ikke anvendt for udbuddet - men bemærkning om udbuddet er af systemtekniske årsager anført i beskrivelsesfeltet hertil.
›
Financial ratio required
Udbuddet er et offentligt udbud, og der gælder ikke nogen minimumskrav til egnethed. Kriterium ”finansielt forhold” er således ikke anvendt for udbuddet - men bemærkning om udbuddet er af systemtekniske årsager anført i beskrivelsesfeltet hertil.
›
Financial ratio required
Udbuddet er et offentligt udbud, og der gælder ikke nogen minimumskrav til egnethed. Kriterium ”finansielt forhold” er således ikke anvendt for udbuddet - men bemærkning om udbuddet er af systemtekniske årsager anført i beskrivelsesfeltet hertil.
›
Financial ratio required
Udbuddet er et offentligt udbud, og der gælder ikke nogen minimumskrav til egnethed. Kriterium ”finansielt forhold” er således ikke anvendt for udbuddet - men bemærkning om udbuddet er af systemtekniske årsager anført i beskrivelsesfeltet hertil.
›
Financial ratio required
Udbuddet er et offentligt udbud, og der gælder ikke nogen minimumskrav til egnethed. Kriterium ”finansielt forhold” er således ikke anvendt for udbuddet - men bemærkning om udbuddet er af systemtekniske årsager anført i beskrivelsesfeltet hertil.
Requirement texts are quoted in the notice's original language — the official wording is binding.
Contract
BuyerAmgros I/S
TypeSupplies
Estimated value314.000.000 €
Published7 September 2026
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Orifarm A/S | 83 | 2024–2026 |
| 2care4 ApS · Esbjerg | 69 | 2024–2026 |
| Abacus Medicine A/S · Kopenhagen | 65 | 2024–2026 |
| Sandoz A/S | 52 | 2024–2026 |
| Pfizer ApS | 44 | 2024–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2024353
2025436
2026243
20261
Who knows the rhythm prepares instead of reacting.
·
days until the deadline — Friday 16 October at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tender documents — direct download
Specifications and annexes hosted by the buyer — usually accessible without registration.
Tenders like this, every morning at 7:30 in your inbox.
Register now →